| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/02/2002 | EP1200608A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 05/02/2002 | EP1200607A2 Tet repressor-based transcriptional regulatory proteins |
| 05/02/2002 | EP1200606A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 05/02/2002 | EP1200605A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 05/02/2002 | EP1200604A1 Production of proteins |
| 05/02/2002 | EP1200603A1 Production of proteins by autoproteolytic cleavage |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200601A1 Method for the production of l-amino acids from their racemic n-acetyl-d, l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes |
| 05/02/2002 | EP1200600A2 Monocellular or multicellular organisms for the production of riboflavin |
| 05/02/2002 | EP1200599A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 05/02/2002 | EP1200598A2 Method for production of transgenic plants with increased tocopherol content |
| 05/02/2002 | EP1200597A1 Method for preparing 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200594A2 Protective antigen of epstein barr virus |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200592A2 Mammalian cytokines; related reagents |
| 05/02/2002 | EP1200591A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 05/02/2002 | EP1200590A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 05/02/2002 | EP1200589A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 05/02/2002 | EP1200588A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200585A1 T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof |
| 05/02/2002 | EP1200584A1 Splice variants of cd40-receptor |
| 05/02/2002 | EP1200583A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200580A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 05/02/2002 | EP1200579A2 Antisense therapy for hormone-regulated tumors |
| 05/02/2002 | EP1200578A1 Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
| 05/02/2002 | EP1200577A2 In vitro selection and optional identification of polypeptides using solid support carriers |
| 05/02/2002 | EP1200576A2 Dna's encoding proteins with signal peptides |
| 05/02/2002 | EP1200575A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 05/02/2002 | EP1200573A1 Antisense modulation of mekk1 expression |
| 05/02/2002 | EP1200572A1 Antisense modulation of liver glycogen phosphorylase expression |
| 05/02/2002 | EP1200570A1 Antisense modulation of p13 kinase p110 delta expression |
| 05/02/2002 | EP1200569A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 05/02/2002 | EP1200568A2 Purine metabolism genes in plants |
| 05/02/2002 | EP1200566A2 Glucoamylase variant |
| 05/02/2002 | EP1200563A1 Attenuated influenza virus useful as vaccine |
| 05/02/2002 | EP1200562A2 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 05/02/2002 | EP1200560A1 Melanin-concentrating hormone receptor |
| 05/02/2002 | EP1200559A2 Muscle cells and their use in cardiac repair |
| 05/02/2002 | EP1200557A1 Method of making plant artificial chromosomes |
| 05/02/2002 | EP1200555A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 05/02/2002 | EP1200553A1 Metabolic engineering of amino acid production |
| 05/02/2002 | EP1200552A2 Expression in plants of starch binding domains and/or of protein fusions containing starch binding domains |
| 05/02/2002 | EP1200479A1 Multiple cytokine-antibody complexes |
| 05/02/2002 | EP1200477A1 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 05/02/2002 | EP1200476A1 Antitumor antibodies, proteins, and uses thereof |
| 05/02/2002 | EP1200475A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 05/02/2002 | EP1200474A1 Human g-protein coupled receptor |
| 05/02/2002 | EP1200472A1 Odorant receptors |
| 05/02/2002 | EP1200469A2 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 05/02/2002 | EP1200467A1 Novel human calcium sensitive potassium channel subunits |
| 05/02/2002 | EP1200466A2 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| 05/02/2002 | EP1200459A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/02/2002 | EP1200456A1 Antisense modulation of pten expression |
| 05/02/2002 | EP1200191A1 Low volume chemical and biochemical reaction system |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200131A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/02/2002 | EP1200130A2 Methods for treating therapy-resistant tumors |
| 05/02/2002 | EP1200124A1 Immunoglobulin fusion proteins |
| 05/02/2002 | EP1200120A1 Pneumococcal vaccines |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP1200117A2 Lipoprotein lipase (lpl) variant therapeutics |
| 05/02/2002 | EP1200116A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 05/02/2002 | EP1200114A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/02/2002 | EP1200113A2 Reagents and methods useful for detecting diseases of the prostate |
| 05/02/2002 | EP1200112A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 05/02/2002 | EP1200105A1 Modified factor viii |
| 05/02/2002 | EP1200097A2 Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation |
| 05/02/2002 | EP1157114A4 Genetically engineered retroviral vector particles capable of infecting non-dividing cells |
| 05/02/2002 | EP1135478A4 Activated cation channel of the osteoblast as a mechanism of bone anabolism |
| 05/02/2002 | EP1036202B1 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
| 05/02/2002 | EP0904031A4 Cationic polymer/lipid nucleic acid delivery vehicles |
| 05/02/2002 | EP0859854B1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences |
| 05/02/2002 | EP0843722A4 Regulated autocrine growth of mammalian cells |
| 05/02/2002 | EP0573500B2 Fused genes and their use for determining the presence of metals or of xenobiotic compounds |
| 05/02/2002 | EP0455665B1 Hybrid seed production |
| 05/02/2002 | DE10053519A1 Expression cassette containing plant myb11 promoter, useful for preparing transgenic plants, provides specific expression in flowers and embryonal epidermis |
| 05/02/2002 | DE10051175A1 Cytochrom P450 Monoxygenasen aus thermophilen Bakterien Cytochrome P450 monooxygenases from thermophilic bacteria |
| 05/02/2002 | DE10049587A1 Vektorsystem für Pflanzen Vector system for plants |
| 05/02/2002 | DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
| 05/02/2002 | DE10046894A1 Multicomponent composition for substrate oxidation, useful e.g. for bleaching cellulose, comprises CotA protein and oxygen, effective at high pH |
| 05/02/2002 | CA2464228A1 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | CA2457111A1 Vaccine for treating allergy |
| 05/02/2002 | CA2431178A1 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 05/02/2002 | CA2429044A1 Secreted alpha-helical cytokine-like protein zlmda24 |
| 05/02/2002 | CA2428907A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 05/02/2002 | CA2427312A1 Engineered chimera of protein fragments and methods of use thereof |
| 05/02/2002 | CA2427109A1 In vitro selection of signaling aptamers |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427070A1 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | CA2427068A1 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2426896A1 Compositions and methods for the discovery and selection of biological information |
| 05/02/2002 | CA2426887A1 Polypeptides and polynucleodides from haemophilus influenzae and their use |
| 05/02/2002 | CA2426812A1 Detecting specific nucleotide sequences |